Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5 clinical trials
A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma

An open-label, randomised, controlled, multi-centre, trial with disease free survival as the primary end point. The worldwide collaboration is referred to as GLOBAL BALLAD and consists of a number of individual parallel prospective studies addressing the same objectives with similar designs brought together under the framework of the International Rare …

adenocarcinoma
metastasis
blood transfusion
adjuvant chemotherapy
adjuvant
  • 0 views
  • 19 Feb, 2024
A Study of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

The purpose of this study is to evaluate the safety of Guselkumab in participants with Crohn's disease.

ileitis
stomach pain
ileocolitis
endoscopy
crohn's disease
  • 0 views
  • 19 Feb, 2024
The Intensive Post Exclusive Enteral Nutrition Study

Crohn's disease (CD) is a chronic inflammatory condition with phases where the disease is active and other, where there are no symptoms.

crohn's disease
enteral nutrition
tube feeding
  • 0 views
  • 19 Feb, 2024
Inflammatory Bowel Disease (IBD) Research Registry

Patients seen at the Center for Inflammatory Bowel Disease will be asked to provide their written informed consent (authorization) to allow their identifiable medical record information related to their Inflammatory Bowel Disease to be placed in Center's Research Registry for the purpose of facilitating retrospective research studies directed at Inflammatory …

  • 0 views
  • 19 Feb, 2024
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease

The purpose of this study is to estimate and compare the incidence of overall malignancy, serious infection, and opportunistic infections between new users of ustekinumab and new users of other biologic therapies among adult participants with Crohn's disease (CD).

opportunistic infection
biologics
ustekinumab
crohn's disease
malignancy
  • 0 views
  • 19 Feb, 2024